dr. reddy's labs glp-1 receptor agonist Laboratories has received approval from Health Canada for its generic semaglutide injection, strengthening the Indian drugmaker's presence in the fast-growing global market for diabetes therapies. The company said on GLP-1 Receptor Agonists: The New

When to Be Cautious Although GLP-1 receptor agonists appear to be safe for most individuals, there are exceptions

Cardiovascular risk factors Weight loss achieved with retatrutide has been associated with improvements in several cardiovascular risk markers, including: lower blood pressure improved cholesterol profiles reduced triglyceride levels better insulin sensitivity As with other GLP-1-based therapies, dedicated cardiovascular outcome trials are needed to establish whether these improvements lead to reductions in heart attack, stroke or cardiovascular death

Retinol: The Real Comparison This is where the conversation usually goes sideways

But which one is more suitable for you